B cell class switch recombination is regulated by DYRK1A through MSH6 phosphorylation.

Area of Science:

• Immunology
• Molecular Biology
• Virology

Background:

• Antibody production, specifically immunoglobulin isotype switching, is vital for combating viral infections and enabling vaccine efficacy.
• The precise molecular mechanisms governing B cell immune responses, including class switch recombination (CSR), require further elucidation for therapeutic targeting.

Purpose of the Study:

• To investigate the role of the protein kinase DYRK1A in B cell-mediated immunity, particularly in the context of viral protection and vaccination.
• To identify the molecular targets and mechanisms through which DYRK1A regulates B cell functions, including CSR and germinal center (GC) dynamics.

Main Methods:

• Utilized B cells deficient in Dyrk1a to assess CSR activity both in vivo and in vitro.
• Employed phosphoproteomic screens and kinase-activity assays to identify direct substrates of DYRK1A.
• Investigated the impact of DYRK1A on B cell proliferation following CSR and GC seeding.

Main Results:

• B cells lacking Dyrk1a exhibited significant impairments in CSR activity.
• MSH6, a DNA mismatch repair protein, was identified as a direct substrate of DYRK1A, with a specific phosphorylation site crucial for CSR.
• DYRK1A was found to be essential for attenuating B cell proliferation after CSR and germinal center formation.

Conclusions:

• DYRK1A plays an essential role in regulating B cell immune responses, particularly in antibody class switch recombination and subsequent B cell proliferation.
• The findings highlight DYRK1A-mediated mechanisms that are critical for effective humoral immunity against viral infections and vaccination.
• These insights offer potential therapeutic strategies for manipulating B cell responses in autoimmune diseases mediated by antibodies.